200 Participants Needed

3D-Printed Nasal Irrigation Device for Chronic Rhinosinusitis

KZ
ZT
Overseen ByZachary T. Root, BS
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Ohio State University
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

Three-dimensional (3D) printing has been an emerging technology with uses in a wide array of fields. This research aims to use 3D printing as a tool to provide personalized education to maximize treatment efficacy based on the patient's individual anatomy. With increased irrigation to the sinuses, we hypothesize there will be improved patient satisfaction and higher quality of life. The outcomes of this research could lead to a new option for patients who live with chronic rhinosinusitis are not candidates for surgery or are interested in less invasive options. The 3D printed nasal replica is not something that would be implanted, rather it is a hand-held device used specifically for participants to better understand their nasal anatomy.

Do I need to stop my current medications for the trial?

The trial information does not specify whether you need to stop taking your current medications.

What data supports the effectiveness of the 3D-printed nasal irrigation device for chronic rhinosinusitis treatment?

Research shows that 3D printing can help plan and improve the delivery of sinus irrigation, which is important for treating sinus problems. This suggests that using a 3D-printed device might make nasal irrigation more effective by ensuring the treatment reaches the right areas.12345

Is the 3D-printed nasal irrigation device safe for use in humans?

There is no specific safety data on the 3D-printed nasal irrigation device itself, but a study on 3D printer emissions showed slight reductions in lung function and minor changes in nasal secretions, suggesting potential mild effects from 3D printing materials.16789

How does the 3D-printed nasal irrigation device for chronic rhinosinusitis differ from other treatments?

This treatment is unique because it uses 3D printing to create a customized nasal irrigation device that can better target the sinuses, potentially improving the delivery and effectiveness of the irrigation compared to standard devices.13101112

Eligibility Criteria

This trial is for individuals with chronic rhinosinusitis, with or without nasal polyps. It's not suitable for those with certain connective tissue disorders like granulomatosis with polyangiitis, significant atopy, cystic fibrosis, or pregnant individuals.

Inclusion Criteria

I have chronic sinusitis, with or without nasal polyps.

Exclusion Criteria

You have a serious allergy condition.
I have a condition like granulomatosis with polyangiitis.
I have cystic fibrosis.
See 2 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive personalized nasal irrigation treatment using 3D-printed nasal replicas for 8 weeks

8 weeks
1 in-person training session

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

Treatment Details

Interventions

  • 3D Printing
Trial Overview The study tests if a personalized education tool made using 3D printing can improve nasal irrigation outcomes in patients by considering their unique anatomy. The goal is to enhance satisfaction and quality of life for those who cannot undergo surgery.
Participant Groups
3Treatment groups
Experimental Treatment
Active Control
Group I: Model groupExperimental Treatment1 Intervention
Finally, the model group (MG) irrigated in an optimal position based on their 3D nasal replica. This patient-specific position was communicated to each MG patient with clear instructions during an in-person training session.
Group II: Backfill groupExperimental Treatment1 Intervention
Backfill group (BG) subjects irrigated with a head tilt of 90 degrees ear-to-shoulder and used the nostril closest to the ground.
Group III: Control groupActive Control1 Intervention
The control group (CG) irrigated in the standard FDA consumer-recommended position, defined as leaning forward with a natural ear-to-shoulder head tilt.

Find a Clinic Near You

Who Is Running the Clinical Trial?

Ohio State University

Lead Sponsor

Trials
891
Recruited
2,659,000+

References

3D Printing as a Planning Tool to Optimize Sinonasal Irrigation. [2023]
[Endoscopic sinus surgery for recurrent sinusitis and nasal polyps]. [2014]
Repetitive simulation training with novel 3D-printed sinus models for functional endoscopic sinus surgeries. [2022]
Comparison of Sinus Deposition from an Aqueous Nasal Spray and Pressurised MDI in a Post-Endoscopic Sinus Surgery Nasal Replica. [2022]
Computational fluid dynamics simulation to compare large volume irrigation and continuous spraying during nasal irrigation. [2020]
Optimized gravity-driven intranasal drop administration delivers significant doses to the ostiomeatal complex and maxillary sinus. [2023]
Preliminary efficacy of fluticasone delivered by a novel device in recalcitrant chronic rhinosinusitis. [2021]
Sinus penetration of saline solution irrigation and atomizer in a cadaveric polyp and allergic fungal sinusitis model. [2020]
Effect of experimental exposures to 3-D printer emissions on nasal allergen responses and lung diffusing capacity for inhaled carbon monoxide/nitric oxide in subjects with seasonal allergic rhinitis. [2023]
Three-Dimensional Printing of the Nasal Cavities for Clinical Experiments. [2021]
11.United Statespubmed.ncbi.nlm.nih.gov
An adjustable, butterfly-design, titanium-expanded polytetrafluoroethylene implant for nasal valve dysfunction: a pilot study. [2013]
Three dimensional printing: A review on the utility within medicine and otolaryngology. [2018]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security